Patents by Inventor Eric Werner

Eric Werner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Endoglin peptides to treat fibrotic diseases
    Patent number: 11590201
    Abstract: In certain aspects, the present disclosure relates to the insight that a polypeptide comprising a truncated, ligand-binding portion of the extracellular domain of endoglin (ENG) polypeptide may be used to treat fibrotic disorders.
    Type: Grant
    Filed: September 5, 2019
    Date of Patent: February 28, 2023
    Assignee: ACCELERON PHARMA, INC.
    Inventors: Asya Grinberg, Roselyne Castonguay, Eric Werner, Ravindra Kumar
  • ENDOGLIN POLYPEPTIDES AND USES THEREOF
    Publication number: 20210300991
    Abstract: In certain aspects, the present disclosure relates to the insight that a polypeptide comprising a truncated, ligand-binding portion of the extracellular domain of endoglin (ENG) polypeptide may be used to inhibit angiogenesis in vivo, particularly in mammals suffering angiogenesis-related disorders.
    Type: Application
    Filed: March 18, 2021
    Publication date: September 30, 2021
    Applicant: Acceleron Pharma Inc.
    Inventors: Asya Grinberg, Roselyne Castonguay, Eric Werner, Ravindra Kumar
  • Endoglin polypeptides and uses thereof
    Patent number: 10981972
    Abstract: In certain aspects, the present disclosure relates to the insight that a polypeptide comprising a truncated, ligand-binding portion of the extracellular domain of endoglin (ENG) polypeptide may be used to inhibit angiogenesis in vivo, particularly in mammals suffering angiogenesis-related disorders.
    Type: Grant
    Filed: February 28, 2018
    Date of Patent: April 20, 2021
    Assignee: Acceleron Pharma Inc.
    Inventors: Asya Grinberg, Roselyne Castonguay, Eric Werner, Ravindra Kumar
  • ENDOGLIN PEPTIDES TO TREAT FIBROTIC DISEASES
    Publication number: 20200164029
    Abstract: In certain aspects, the present disclosure relates to the insight that a polypeptide comprising a truncated, ligand-binding portion of the extracellular domain of endoglin (ENG) polypeptide may be used to treat fibrotic disorders.
    Type: Application
    Filed: September 5, 2019
    Publication date: May 28, 2020
    Applicant: Acceleron Pharma Inc.
    Inventors: Asya Grinberg, Roselyne Castonguay, Eric Werner, Ravindra Kumar
  • Assembly and process for a press feed mechanism for providing rapid, efficient and tuned hold and release displacement of an upper feed roller relative to a lower roller and between which is communicated a sheet material for subsequent feeding into a press operation
    Patent number: 10118785
    Abstract: A feed assembly for transferring an uncoiled sheet material to a downstream material forming operation. The assembly includes upper and lower feed rolls between which the sheet material passes, the upper roll being actuated between engaging or disengaging positions relative to an upper surface of the sheet material. At least one continuous force applying component is provided for exerting a hold down force against the upper feed roll and, in combination, a programmable counterbalance component is calibrated to counter the hold down force exerted by the force applying component and in order to cycle the upper roller between the engaged and disengaged positions during advance cycling of the uncoiled material to the downstream forming operation.
    Type: Grant
    Filed: February 23, 2016
    Date of Patent: November 6, 2018
    Assignee: CHS AUTOMATION
    Inventors: Dave Reiman, Eric Werner
  • ENDOGLIN POLYPEPTIDES AND USES THEREOF
    Publication number: 20180258156
    Abstract: In certain aspects, the present disclosure relates to the insight that a polypeptide comprising a truncated, ligand-binding portion of the extracellular domain of endoglin (ENG) polypeptide may be used to inhibit angiogenesis in vivo, particularly in mammals suffering angiogenesis-related disorders.
    Type: Application
    Filed: February 28, 2018
    Publication date: September 13, 2018
    Applicant: Acceleron Pharma, Inc.
    Inventors: Asya Grinberg, Roselyne Castonguay, Eric Werner, Ravindra Kumar
  • Endoglin polypeptides and uses thereof
    Patent number: 9932386
    Abstract: In certain aspects, the present disclosure relates to the insight that a polypeptide comprising a truncated, ligand-binding portion of the extracellular domain of endoglin (ENG) polypeptide may be used to inhibit angiogenesis in vivo, particularly in mammals suffering angiogenesis-related disorders.
    Type: Grant
    Filed: April 19, 2012
    Date of Patent: April 3, 2018
    Assignee: Acceleron Pharma, Inc.
    Inventors: Asya Grinberg, Roselyne Castonguay, Eric Werner, Ravindra Kumar
  • Variable geometry flush boundary diverter
    Patent number: 9862482
    Abstract: An airflow diverter system for an aircraft may include an external aircraft surface upstream from an engine inlet and a passage having an upstream opening adjacent the engine inlet. The passage may be configured to channel boundary airflow from the external aircraft surface away from the engine inlet. The diverter system may include an occlusion device configured to selectively open and close the opening to the passage.
    Type: Grant
    Filed: September 4, 2015
    Date of Patent: January 9, 2018
    Assignee: The Boeing Company
    Inventors: Thuy Huynh, Eric Werner
  • VARIABLE GEOMETRY FLUSH BOUNDARY DIVERTER
    Publication number: 20170066527
    Abstract: An airflow diverter system for an aircraft may include an external aircraft surface upstream from an engine inlet and a passage having an upstream opening adjacent the engine inlet. The passage may be configured to channel boundary airflow from the external aircraft surface away from the engine inlet. The diverter system may include an occlusion device configured to selectively open and close the opening to the passage.
    Type: Application
    Filed: September 4, 2015
    Publication date: March 9, 2017
    Applicant: THE BOEING COMPANY
    Inventors: Thuy Huynh, Eric Werner
  • ASSEMBLY AND PROCESS FOR A PRESS FEED MECHANISM FOR PROVIDING RAPID, EFFICIENT AND TUNED HOLD AND RELEASE DISPLACEMENT OF AN UPPER FEED ROLLER RELATIVE TO A LOWER ROLLER AND BETWEEN WHICH IS COMMUNICATED A SHEET MATERIAL FOR SUBSEQUENT FEEDING INTO A PRESS OPERATION
    Publication number: 20160251189
    Abstract: A feed assembly for transferring an uncoiled sheet material to a downstream material forming operation. The assembly includes upper and lower feed rolls between which the sheet material passes, the upper roll being actuated between engaging or disengaging positions relative to an upper surface of the sheet material. At least one continuous force applying component is provided for exerting a hold down force against the upper feed roll and, in combination, a programmable counterbalance component is calibrated to counter the hold down force exerted by the force applying component and in order to cycle the upper roller between the engaged and disengaged positions during advance cycling of the uncoiled material to the downstream forming operation.
    Type: Application
    Filed: February 23, 2016
    Publication date: September 1, 2016
    Inventors: Dave Reiman, Eric Werner
  • ENDOGLIN PEPTIDES TO TREAT FIBROTIC DISEASES
    Publication number: 20150202260
    Abstract: In certain aspects, the present disclosure relates to the insight that a polypeptide comprising a truncated, ligand-binding portion of the extracellular domain of endoglin (ENG) polypeptide may be used to treat fibrotic disorders.
    Type: Application
    Filed: October 24, 2014
    Publication date: July 23, 2015
    Inventors: Asya Grinberg, Roselyne Castonguay, Eric Werner, Ravindra Kumar